UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

The lancet oncology, 2010-08, Vol.11 (8), p.733-740

2010

Volltextzugriff (PDF)

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-11, Vol.24 (31), p.5034-5042

2006

Volltextzugriff (PDF)

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study

Clinical cancer research, 2006-10, Vol.12 (20), p.6049-6055

2006

Volltextzugriff (PDF)

Lung cancer after treatment for Hodgkin's lymphoma: a systematic review

The lancet oncology, 2005-10, Vol.6 (10), p.773-779

2005

Volltextzugriff (PDF)

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2009-04, Vol.64 (1), p.60-65

2009

Volltextzugriff (PDF)

Where next for gefitinib in patients with lung cancer?

The lancet oncology, 2006-06, Vol.7 (6), p.499-507

2006

Volltextzugriff (PDF)

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

The Lancet (British edition), 2005-10, Vol.366 (9496), p.1527-1537

2005

Volltextzugriff (PDF)

Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial

JAMA oncology, 2018-12, Vol.4 (12), p.e183486

2018

Volltextzugriff (PDF)

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer

Clinical lung cancer, 2018-03, Vol.19 (2), p.130-138.e2

2018

Volltextzugriff (PDF)

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

Lung cancer (Amsterdam, Netherlands), 2012-12, Vol.78 (3), p.276-281

2012

Volltextzugriff (PDF)

Randomized Trial of Paclitaxel Plus Supportive Care Versus Supportive Care for Patients With Advanced Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2000-07, Vol.92 (13), p.1074-1080

2000

Volltextzugriff (PDF)

A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2010-08, Vol.5 (8), p.1285-1288

2010

Volltextzugriff (PDF)

Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non–Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial

Clinical lung cancer, 2011-11, Vol.12 (6), p.407-411

2011

Volltextzugriff (PDF)

Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2005-05, Vol.97 (9), p.666-674

2005

Volltextzugriff (PDF)

Standard versus Dose-Intensified Chemotherapy with Sequential Reinfusion of Hematopoietic Progenitor Cells in Small Cell Lung Cancer Patients with Favorable Prognosis

Journal of thoracic oncology, 2007-01, Vol.2 (1), p.51-58

2007

Volltextzugriff (PDF)

The influence of sex in non-small cell lung cancer

Onkologie, 2009-10, Vol.32 (10), p.547-548

2009

Volltextzugriff (PDF)

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients

Journal of clinical oncology, 1998-09, Vol.16 (9), p.2921-2929

1998

Volltextzugriff (PDF)

Clinical Experience with Gefitinib in Indian Patients

Journal of thoracic oncology, 2008-04, Vol.3 (4), p.380-385

2008

Volltextzugriff (PDF)

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

Journal of thoracic oncology, 2006-10, Vol.1 (8), p.847-855

2006

Volltextzugriff (PDF)

Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy

Journal of clinical oncology, 1991-08, Vol.9 (8), p.1446-1452

1991

Volltextzugriff (PDF)

High‐dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma

Cancer, 1989-04, Vol.63 (7), p.1296-1302

1989

Volltextzugriff (PDF)

In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue

Cancer chemotherapy and pharmacology, 1992, Vol.31 (3), p.240-246

1992

Volltextzugriff (PDF)

A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion

Cancer chemotherapy and pharmacology, 1987-01, Vol.20 (4), p.327-331

1987

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Life Sciences & Biomedicine
(29)
Middle Aged
(29)
Science & Technology
(29)
Female
(28)
Male
(28)
Aged
(27)
Oncology
(26)
Lung Neoplasms - Drug Therapy
(20)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(13)
Aged, 80 And Over
(12)
Biological And Medical Sciences
(12)
Lung Neoplasms - Pathology
(12)
Medical Sciences
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Chemotherapy
(11)
Survival Analysis
(11)
Lung Neoplasms - Mortality
(10)
Neoplasm Staging
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study

Lung cancer after treatment for Hodgkin's lymphoma: a systematic review

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

Where next for gefitinib in patients with lung cancer?

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

Randomized Trial of Paclitaxel Plus Supportive Care Versus Supportive Care for Patients With Advanced Non-Small-Cell Lung Cancer

A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer

Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer

Standard versus Dose-Intensified Chemotherapy with Sequential Reinfusion of Hematopoietic Progenitor Cells in Small Cell Lung Cancer Patients with Favorable Prognosis

The influence of sex in non-small cell lung cancer

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients

Clinical Experience with Gefitinib in Indian Patients

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy

High‐dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma

In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue

A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion

Aktive Filter

Suchergebnisse filtern